Literature DB >> 18790951

Frequently asked questions in the medical management of high-grade glioma: a short guide with practical answers.

R Stupp1, A F Hottinger, M J van den Bent, P-Y Dietrich, A A Brandes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18790951     DOI： 10.1093/annonc/mdn474

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  16 in total

1.  A long noncoding RNA UCA1 promotes proliferation and predicts poor prognosis in glioma.

Authors:  W Zhao; C Sun; Z Cui
Journal:  Clin Transl Oncol       Date:  2017-01-19       Impact factor: 3.405

2.  A novel bicistronic high-capacity gutless adenovirus vector that drives constitutive expression of herpes simplex virus type 1 thymidine kinase and tet-inducible expression of Flt3L for glioma therapeutics.

Authors:  Mariana Puntel; A K M G Muhammad; Marianela Candolfi; Alireza Salem; Kader Yagiz; Catherine Farrokhi; Kurt M Kroeger; Weidong Xiong; James F Curtin; Chunyan Liu; Niyati S Bondale; Jonathan Lerner; Robert N Pechnick; Donna Palmer; Philip Ng; Pedro R Lowenstein; Maria G Castro
Journal:  J Virol       Date:  2010-04-07       Impact factor: 5.103

Review 3.  Gene therapy and targeted toxins for glioma.

Authors:  Maria G Castro; Marianela Candolfi; Kurt Kroeger; Gwendalyn D King; James F Curtin; Kader Yagiz; Yohei Mineharu; Hikmat Assi; Mia Wibowo; A K M Ghulam Muhammad; David Foulad; Mariana Puntel; Pedro R Lowenstein
Journal:  Curr Gene Ther       Date:  2011-06       Impact factor: 4.391

Review 4.  Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics.

Authors:  Camilla Krakstad; Martha Chekenya
Journal:  Mol Cancer       Date:  2010-06-01       Impact factor: 27.401

5.  Supportive follow-up in patients treated with radical intent for high-grade glioma.

Authors:  Susan Catt; Anthony Chalmers; Giles Critchley; Lesley Fallowfield
Journal:  CNS Oncol       Date:  2012-09

6.  Wittig derivatization of sesquiterpenoid polygodial leads to cytostatic agents with activity against drug resistant cancer cells and capable of pyrrolylation of primary amines.

Authors:  Ramesh Dasari; Annelise De Carvalho; Derek C Medellin; Kelsey N Middleton; Frédéric Hague; Marie N M Volmar; Liliya V Frolova; Mateus F Rossato; Jorge J De La Chapa; Nicholas F Dybdal-Hargreaves; Akshita Pillai; Roland E Kälin; Véronique Mathieu; Snezna Rogelj; Cara B Gonzales; João B Calixto; Antonio Evidente; Mathieu Gautier; Gnanasekar Munirathinam; Rainer Glass; Patricia Burth; Stephen C Pelly; Willem A L van Otterlo; Robert Kiss; Alexander Kornienko
Journal:  Eur J Med Chem       Date:  2015-08-29       Impact factor: 6.514

7.  Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastoma.

Authors:  Mariana Puntel; Ghulam Muhammad A K M; Catherine Farrokhi; Nathan Vanderveen; Christopher Paran; Ashley Appelhans; Kurt M Kroeger; Alireza Salem; Liliana Lacayo; Robert N Pechnick; Kyle R Kelson; Sukhpreet Kaur; Sean Kennedy; Donna Palmer; Philip Ng; Chunyan Liu; Johnny Krasinkiewicz; Pedro R Lowenstein; Maria G Castro
Journal:  Toxicol Appl Pharmacol       Date:  2013-02-09       Impact factor: 4.219

8.  Fungal metabolite ophiobolin A as a promising anti-glioma agent: In vivo evaluation, structure-activity relationship and unique pyrrolylation of primary amines.

Authors:  Ramesh Dasari; Marco Masi; Romana Lisy; Marlène Ferdérin; Lance R English; Alessio Cimmino; Véronique Mathieu; Andrew J Brenner; John G Kuhn; Steven T Whitten; Antonio Evidente; Robert Kiss; Alexander Kornienko
Journal:  Bioorg Med Chem Lett       Date:  2015-08-24       Impact factor: 2.823

9.  5,10b-Ethanophenanthridine amaryllidaceae alkaloids inspire the discovery of novel bicyclic ring systems with activity against drug resistant cancer cells.

Authors:  Sean Henry; Ria Kidner; Mary R Reisenauer; Igor V Magedov; Robert Kiss; Véronique Mathieu; Florence Lefranc; Ramesh Dasari; Antonio Evidente; Xiaojie Yu; Xiuye Ma; Alexander Pertsemlidis; Regina Cencic; Jerry Pelletier; David A Cavazos; Andrew J Brenner; Alexander V Aksenov; Snezna Rogelj; Alexander Kornienko; Liliya V Frolova
Journal:  Eur J Med Chem       Date:  2016-05-06       Impact factor: 6.514

10.  Study of the efficacy, biodistribution, and safety profile of therapeutic gutless adenovirus vectors as a prelude to a phase I clinical trial for glioblastoma.

Authors:  A K M G Muhammad; M Puntel; M Candolfi; A Salem; K Yagiz; C Farrokhi; K M Kroeger; W Xiong; J F Curtin; C Liu; K Lawrence; N S Bondale; J Lerner; G J Baker; D Foulad; R N Pechnick; D Palmer; P Ng; P R Lowenstein; M G Castro
Journal:  Clin Pharmacol Ther       Date:  2010-02-17       Impact factor: 6.875
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.